gptkbp:instance_of
|
gptkb:castle
|
gptkbp:bfsLayer
|
3
|
gptkbp:bfsParent
|
gptkb:castle
|
gptkbp:affects
|
lymph nodes
multiple lymph node regions
|
gptkbp:can_be
|
organ dysfunction
|
gptkbp:can_lead_to
|
gptkb:healthcare_organization
immune system dysfunction
|
gptkbp:caused_by
|
gptkb:fandom
thrombocytopenia
hypergammaglobulinemia
|
gptkbp:current_use
|
requires ongoing management
can affect quality of life
|
gptkbp:first_described_by
|
gptkb:1978
|
gptkbp:focuses_on
|
gptkb:hospital
patient advocacy
|
gptkbp:has_achievements
|
secondary infections
|
https://www.w3.org/2000/01/rdf-schema#label
|
multicentric Castleman's disease
|
gptkbp:is_affected_by
|
viral infections
|
gptkbp:is_associated_with
|
autoimmune diseases
HIV infection
lymphoproliferative disorders
fever of unknown origin
|
gptkbp:is_characterized_by
|
lymphadenopathy
systemic symptoms
enlarged lymph nodes
|
gptkbp:is_considered_as
|
rare disease
|
gptkbp:is_involved_in
|
plasma cells
|
gptkbp:is_known_for
|
MCD
|
gptkbp:is_linked_to
|
gptkb:healthcare_organization
plasma cell disorders
|
gptkbp:is_often_associated_with
|
late stages
|
gptkbp:is_often_depicted_as
|
other lymphoproliferative disorders
|
gptkbp:is_often_used_in
|
adults
|
gptkbp:is_recognized_by
|
gptkb:the_World_Health_Organization
|
gptkbp:is_studied_in
|
clinical trials
|
gptkbp:is_used_for
|
fatigue
swelling
|
gptkbp:requires
|
surgical intervention
long-term follow-up
|
gptkbp:scientific_classification
|
idiopathic
|
gptkbp:social_responsibility
|
blood tests
imaging studies
clinical evaluation
biopsy
|
gptkbp:subject
|
case studies
|
gptkbp:symptoms
|
weight loss
fever
night sweats
|
gptkbp:treatment
|
gptkb:vaccine
targeted therapies
chemotherapy
corticosteroids
hematologists
specialized centers
|
gptkbp:type_of
|
gptkb:non-Hodgkin_lymphoma
|